Abbott Laboratories · ABT
As of the latest run, Abbott Laboratories (ABT) scores 34/100 overall — a fragile profile across several dimensions. Its strongest dimension: momentum (69/100); the one that most warrants attention: profitability (0/100).
Three pillars judge the company (profitability, growth, financial health), three judge the stock (valuation, momentum, risk). The score is recomputed every day from Yahoo Finance market data — the one shown above reflects today's state.
Momentum comes in at 69/100 — a well-oriented price trend. Growth comes in at 67/100 — sustained revenue growth.
The breakdown of each pillar — and a plain-English explanation of what it measures — is available in the full analysis, free and updated every day.
Profitability falls to 0/100 — thin margins or a disappointing return on capital. Financial health falls to 0/100 — a balance sheet under strain, on debt or liquidity. The risk pillar falls to 13/100 — high volatility — the stock swings hard, both ways.
No score replaces your own judgment: Stock Analyzer is a tool for analysis and understanding, not investment advice.